New US FDA Powers On Rx Abuse Could Be 'Tailored' By Congress, Gottlieb Suggests

At House hearing on opioid epidemic, FDA Commissioner responds to range of legislative proposals, including those aimed at agency's drug approval and safety monitoring activities.